Ischemic and viable myocardium in patients with Non-Q-Wave or Q-Wave myocardial infarction and left ventricular dysfunction: A clinical study using positron emission tomography, echocardiography, and electrocardiography

Journal of the American College of Cardiology

Volumn 43, Issue 4, 2004, Pages 592-598

  Yang, Hua ^a   Pu, Min ^a,c   Rodriguez, David ^a   Underwood, Donald ^a   Griffin, Brian P ^a   Kalahasti, Vidyasagar ^a   Thomas, James D ^a   Brunken, Richard C ^b  

^a Department of Cardiology ^*  (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Fluorodeoxyglucose 18; Ischemic viable myocardium; Left ventricular ejection fraction; Myocardial infarction; Non Q wave myocardial infarction; Positron emission tomography; Q wave myocardial infarction; Rubidium 82; Wall motion score index

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; RUBIDIUM; RUBIDIUM 82;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART STROKE VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL HIBERNATION; NON Q WAVE HEART INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; Q WAVE HEART INFARCTION; SCAR; SCINTISCANNING; ST SEGMENT DEPRESSION; STRESS;

EID: 1242272749     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.07.052     Document Type: Article

References (40)

1. Sullivan W., Vlodaver Z., Tuna N., Long L., Edwards J.E. Correlation of electrocardiographic and pathologic findings in healed myocardial infarction. Am J Cardiol. 43:1978;724.
2. Freifeld A.G., Schuster E.H., Bulkley B.H. Nontransmural versus transmural myocardial infarction A morphologic study . Am J Med. 75:1983;423-432.
3. Ogawa H., Hiramori K., Haze K., et al. Comparison of clinical features of non-Q-wave and Q-wave myocardial infarction. Am Heart J. 111:1986;513-518.
4. Haim M., Behar S., Boyko V., Hod H., Gottlieb S. The prognosis of a first Q-wave versus non-Q-wave myocardial infarction in the reperfusion era. Am J Med. 108:2000;381-386.
5. Cannon C.P. Optimizing the treatment of unstable angina. J Thromb Thrombolysis. 2:1995;205-218.
6. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction Results of the timi iiib trial (thrombolysis in myocardial ischemia) . Circulation. 90:1994;2569.
7. Ryan T.J., Antman E.M., Brooks N.H., et al. 1999 update Acc/aha guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the american college of cardiology/american heart association task force on practice guidelines (committee on management of acute myocardial infarction) . Circulation. 100:1999;1016-1030.
8. Schulze R.A., Pitt B., Griffith L.S.C., et al. Coronary angiography and left ventriculography in survivors of transmural and nontransmural myocardial infarction. Am J Med. 41:1978;1127-1130.
9. Cannon C.P. Improved management of unstable angina and non-Q-wave MI. Contemp Intern Med. 7:1995;11-12.
10. Wexler L.F., Blaustein A.S., Lavori P.W., Lehmann K.G., Wade M., Boden W.E. Non-Q-wave myocardial infarction following thrombolytic therapy A comparison of outcomes in patients randomized to invasive or conservative post-infarct assessment strategies in the veterans affairs non-q-wave infarction strategies in-hospital (vanqwish) trial . J Am Coll Cardiol. 37:2001;19-25.
11. Armstrong P.W., Fu Y., Chang W.C., et al. Acute coronary syndromes in the GUSTO-IIb trial Prognostic insights and impact of recurrent ischemia . Circulation. 98:1998;1860.
12. Gibson R.S. Non-Q-wave myocardial infarction Diagnosis, prognosis and management . Curr Problems Cardiol. 10:1998;1-72.
13. Boden W.E. Non-Q-wave myocardial infarction Clinical approach to diagnosis and management . O'Rourke R.A. Hurst: The Heart, Update I. 1996;21-40 McGraw-Hill, New York, NY.
14. Pratt C.M., Roberts R. Non-Q-wave myocardial infarction Recognition, pathogenesis, prognosis and management . Cardiol Ser. 36:1985;5-12.
15. Boden W.E., O'Rourke R.A., Crawford M.H., et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy Veterans affairs non-q-wave infarction strategies in hospital (vanqwish) trial investigators . N Engl J Med. 338:1998;1785-1792.
16. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887.
17. Haas F., Haehnel C.J., Picker W., et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol. 30:1997;1693-1700.
18. Sciagra R., Bisi G., Santoro G.M., et al. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting post revascularization recovery. J Am Coll Cardiol. 30:1997;384-391.
19. Udelson J.E. Steps forward in the assessment of myocardial viability in left ventricular dysfunction. Circulation. 97:1998;833-838.
20. Go R.T., MacIntyre W.J., Cook S.A., et al. The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose positron emission tomographic imaging in patients with prior infarction and left ventricular dysfunction. J Nucl Cardiol. 3:1996;96-104.
21. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms . J Am Soc Echocardiogr. 2:1989;358-367.
22. Guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on coronary angiography). J Am Coll Cardiol 1987;10:935-50.
23. Kambara H., Nohara R., Tamaki N., Ono S., Konishi J., Kawai C. Positron emission tomography, usefulness in assessing myocardial viability. Jpn Circ J. 56:1992;608-613.
24. Hashimoto T., Kambara H., Fudo T., et al. Non-Q-wave versus Q-wave myocardial infarction Regional myocardial metabolism and blood flow assessed by positron emission tomography . J Am Coll Cardiol. 12:1988;88-93.
25. Pagley P.R., Beller G.A., Watson D.D., Gimple L.W., Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 96:1997;793-800.
26. Pasquet A., Robert A., D'hondt A.M., Dion R., Melin L.A., Vanoverschelde J.L. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation. 100:1999;141-148.
27. Gioia G., Powers J., Heo J., Iskndrian A.S. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol. 75:1995;759-762.
28. Eitzman D., al-Aouar Z., Kanter H.L., et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 20:1992;559-565.
29. Hahalis G., Stathopoulos C., Apostolopoulos D., Vasilakos P., Alexopoulos D., Manolis A.S. Contribution of the ST elevation/T-wave normalization in Q-wave leads during routine, pre-discharge treadmill exercise test to patient management and risk stratification after acute myocardial infarction A 2.5-year follow-up study . J Am Coll Cardiol. 40:2002;62-70.
30. Lee K.S., Marwick T.H., Cook S.A., et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction Relative efficacy of medical therapy and revascularization . Circulation. 90:1994;2687-2694.
31. Dilsizian V., Rocco T.P., Freedman N.M., Leon M.B., Bonow R.O. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med. 323:1990;141-146.
32. Kiat H., Berman D.S., Maddahi J., et al. Late reversibility of tomographic myocardial thallium-201 defects An accurate marker of myocardial viability . J Am Coll Cardiol. 12:1988;1456-1463.
33. Yang L.D., Berman D.S., Kiat H., et al. The frequency of late reversibility in SPECT thallium-201 stress-redistribution studies. J Am Coll Cardiol. 15:1990;334-340.
34. Picano E., Sicari R., Landi P., et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction A dobutamine stress echocardiographic study . Circulation. 98:1998;1078-1084.
35. Afridi I., Grayburn P.A., Panza J.A., Oh J.K., Zoghbi W.A., Marwick T.H. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol. 32:1998;921-926.
36. Senior R., Kaul S., Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol. 33:1999;1848-1854.
37. Perrone-Filardi P., Pace L., Prastaro M., et al. Assessment of myocardial viability in patients with chronic coronary artery disease Rest-4-hour-24-hour 201tl tomography versus dobutamine echocardiography . Circulation. 94:1996;2712-2719.
38. Baumgartner H., Porenta G., Lau Y.K., et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT Correlation with histopathology in explanted hearts . J Am Coll Cardiol. 32:1998;1701-1708.
39. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 343:2000;1445-1453.
40. Allman K.C., Shaw L.J., Hachamovitch R., Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction A meta-analysis . J Am Coll Cardiol. 39:2002;1151-1158.